ANTITUMOR-ACTIVITY AND SURFACE PHENOTYPES OF HUMAN GLIOMA-INFILTRATING LYMPHOCYTES AFTER INVITRO EXPANSION IN THE PRESENCE OF INTERLEUKIN-2

被引：0
|
作者：
SAWAMURA, Y
HOSOKAWA, M
KUPPNER, MC
KOBAYASHI, H
AIDA, T
ABE, H
DETRIBOLET, N
机构：
[1] HOKKAIDO UNIV,SCH MED,DEPT NEUROSURG,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN
[2] HOKKAIDO UNIV,SCH MED,INST CANC,PATHOL LAB,KITA KU,SAPPORO,HOKKAIDO 060,JAPAN
来源：
CANCER RESEARCH | 1989年 / 49卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：1843 / 1849
页数：7
相关论文
共 50 条
  • [41] EFFECTS OF SYSTEMIC RECOMBINANT INTERLEUKIN-2 ON NATURAL-KILLER AND LYMPHOKINE ACTIVATED KILLER ACTIVITY OF HUMAN-TUMOR INFILTRATING LYMPHOCYTES
    ANDERSON, TM
    IBAYASHI, Y
    TOKUDA, Y
    COLQUHOUN, SD
    HOLMES, EC
    GOLUB, SH
    CANCER RESEARCH, 1988, 48 (05) : 1180 - 1183
  • [42] IMAGING PATTERN OF PREVIOUSLY INVITRO SENSITIZED AND INTERLEUKIN-2 EXPANDED AUTOLOGOUS LYMPHOCYTES IN HUMAN CANCER
    MUKHERJI, B
    ARNBJARNARSON, O
    SPITZNAGLE, LA
    KALISH, RI
    HOFFMAN, J
    ERGIN, MT
    SPENCER, RP
    NUCLEAR MEDICINE AND BIOLOGY, 1988, 15 (04): : 419 - &
  • [43] THE DIFFERENCE IN SURFACE PHENOTYPES BETWEEN CYTO-TOXIC LYMPHOCYTES INDUCED INVIVO BY SYSTEMIC ADMINISTRATION OF HUMAN RECOMBINANT INTERLEUKIN-2 AND LYMPHOKINE ACTIVATED KILLER CELLS INDUCED INVITRO
    OZAKI, A
    NAKANO, H
    MINATO, K
    NAKAGAWA, K
    SASAKI, Y
    SAIJO, N
    EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (06): : 1055 - 1060
  • [44] SCHEDULE DEPENDENCY OF THE ANTITUMOR-ACTIVITY AND TOXICITY OF POLYETHYLENE GLYCOL-MODIFIED INTERLEUKIN-2 IN MURINE TUMOR-MODELS
    ZIMMERMAN, RJ
    AUKERMAN, SL
    KATRE, NV
    WINKELHAKE, JL
    YOUNG, JD
    CANCER RESEARCH, 1989, 49 (23) : 6521 - 6528
  • [45] ENHANCEMENT OF ANTITUMOR-ACTIVITY OF RECOMBINANT INTERLEUKIN-2 (RIL-2) BY IMMUNOCOMPLEXING WITH A MONOCLONAL-ANTIBODY AGAINST RIL-2
    SATO, J
    HAMAGUCHI, N
    DOKEN, K
    GOTOH, K
    OOTSU, K
    IWASA, S
    OGAWA, Y
    TOGUCHI, H
    BIOTHERAPY, 1993, 6 (03) : 225 - 231
  • [46] STUDIES EVALUATING THE ANTITUMOR-ACTIVITY AND TOXICITY OF INTERLEUKIN-15, A NEW T-CELL GROWTH-FACTOR - COMPARISON WITH INTERLEUKIN-2
    MUNGER, W
    DEJOY, SQ
    JEYASEELAN, R
    TORLEY, LW
    GRABSTEIN, KH
    EISENMANN, J
    PAXTON, R
    COX, T
    WICK, MM
    KERWAR, SS
    CELLULAR IMMUNOLOGY, 1995, 165 (02) : 289 - 293
  • [47] MEMBRANE-ASSOCIATED INTERLEUKIN-2 EPITOPES ON THE SURFACE OF HUMAN LYMPHOCYTES-T
    KAPLAN, DR
    BERGMANN, CA
    GOULD, D
    LANDMEIER, B
    JOURNAL OF IMMUNOLOGY, 1988, 140 (03): : 819 - 826
  • [48] EXOGENOUS INTERLEUKIN-2 RECRUITS INVITRO LYMPHOKINE-ACTIVATED KILLER ACTIVITY BY INVIVO ACTIVATED LYMPHOCYTES
    LAMERS, CHJ
    GRATAMA, JW
    VANPUTTEN, WLJ
    STOTER, G
    BOLHUIS, RLH
    CANCER RESEARCH, 1991, 51 (09) : 2324 - 2328
  • [49] TUMOR IMAGING BY IN-111 LABELED LYMPHOCYTES AFTER SENSITIZATION TO AUTOLOGOUS TUMOR AND EXPANSION WITH INTERLEUKIN-2
    MUKHERJI, B
    SPITZNAGLE, LA
    SPENCER, RP
    ARNBJARNARSON, O
    ERGIN, MT
    JOURNAL OF NUCLEAR MEDICINE, 1986, 27 (06) : 970 - 971
  • [50] INVITRO ANTITUMOR-ACTIVITY OF EOSINOPHILS FROM CANCER-PATIENTS TREATED WITH SUBCUTANEOUS ADMINISTRATION OF INTERLEUKIN .2. ROLE OF INTERLEUKIN-5
    RIVOLTINI, L
    VIGGIANO, V
    SPINAZZE, S
    SANTORO, A
    COLOMBO, MP
    TAKATSU, K
    PARMIANI, G
    INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (01) : 8 - 15
12345